Patient-Reported and Clinical Outcomes Among Patients With Calciphylaxis

• Published in: Mayo Clinic proceedings. Innovations, quality & outcomes Vol. 7; no. 1; pp. 81 - 92
• Main Authors: Wen, Wen, Krinsky, Scott, Kroshinsky, Daniela, Durant, Olivia, He, Jeffrey, Seethapathy, Rituvanthikaa, Hillien, Shelsea Annette St, Mengesha, Beza, Malhotra, Rajeev, Chitalia, Vipul, Nazarian, Rosalynn M., Goverman, Jeremy, Lyons, Karen S., Nigwekar, Sagar U.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 01.02.2023; Elsevier
• Subjects: Original; OR; STS; HBO; MME; tPA; IV; QoL; HBO, hyperbaric oxygen; IV, intravenous; QoL, quality of life; MME, morphine milligram equivalent; STS, sodium thiosulphate; OR, odds ratio; tPA, tissue plasminogen activator
• ISSN: 2542-4548; 2542-4548
• DOI: 10.1016/j.mayocpiqo.2022.12.006

To describe the pain intensity among hospitalized patients with calciphylaxis, elucidate the factors associated with pain improvement, and examine the link between pain improvement and clinical outcomes. Patients were identified from the Partners Research Patient Data Registry and the Partners Calciphylaxis Registry and Biorepository (Clinicaltrials.gov ID: NCT03032835). Those with calciphylaxis requiring hospitalization for at least 14 consecutive days during the study period from May 2016 through December 2021 were included. Pain intensity was assessed using patient-reported pain scores on numerical rating scales from 0 to 10. Associations between pain improvement and clinical outcomes, including lesion improvement, amputation, and mortality, were examined using univariate and multivariate regression models. Our analysis included 111 patients (age, 58±14 years; men, 40%; on maintenance dialysis, 79%). No significant improvement of pain intensity was observed over the 14 days of hospitalization (mean difference, −0.71; P=.08). However, among 49 (44.1%) patients who showed at least 1-point improvement in the pain score, there was an association with surgical debridement during hospitalization (odds ratio, 3.37; 95% CI, 1.17-9.67; P=.02). Hyperbaric oxygen therapy was associated with pain improvement (odds ratio, 5.38; 95% CI, 1.14-25.50; P=.03) in patients on maintenance dialysis. Pain improvement was associated with lower rates of subsequent amputation at 6 months of follow up (6% vs 13%; P<.05) but did not predict lesion improvement or survival. Pain control remains a challenge among hospitalized patients with calciphylaxis. Surgical debridement and hyperbaric oxygen therapy may improve pain intensity. Pain improvement predicted a lower risk of future amputation.